| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |